Internisten am Markt Dr. M. Schwerdtfeger, Dr. A. Lehmann
- Address
- Markt 3/4, 06366 Köthen, Germany
Internisten am Markt - Gastroenterology Research Center
Led by Dr. M. Schwerdtfeger and Dr. A. Lehmann, this internal medicine research center specializes in clinical investigations of functional gastrointestinal disorders. The practice demonstrates particular expertise in evaluating novel therapeutic approaches for common digestive conditions that significantly impact quality of life.
- Irritable Bowel Syndrome (IBS-D) treatment strategies
- Probiotic and microbiome-based interventions
- Safety and efficacy assessment of living bacterial therapies
The center's research portfolio includes sophisticated placebo-controlled, double-blind trials examining innovative treatments such as E. coli-based preparations for gastrointestinal symptom management. Their clinical investigations focus on evaluating both the therapeutic effectiveness and tolerability profile of treatments targeting diarrhoea-predominant irritable bowel syndrome, contributing valuable data to the evolving field of microbiome therapeutics in functional bowel disorders.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1SymbioPharm GmbH1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Internisten am Markt Dr. M. Schwerdtfeger, Dr. A. Lehmann
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Escherichia coli DSM 17252 in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial | SymbioPharm GmbH | Phase III | Recruiting | Nov 2019 | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.